Pulocimab
Pulocimab is an anti-VEGFR2 monoclonal antibody (mAb) . Pulocimab can be used for the research of cancers[1].
Product Specifications
Product Name Alternative
AK-109
UNSPSC
12352203
Target
VEGFR
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pulocimab.html
Purity
98.42
Solubility
10 mM in DMSO
Smiles
[Pulocimab]
Molecular Weight
(143.721 kDa)
References & Citations
[1]Keam SJ. Cadonilimab: First Approval. Drugs. 2022 Aug;82 (12) :1333-1339.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99808/Pulocimab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99808/Pulocimab-SDS-MedChemExpress.pdf
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Isoform
VEGFR2/KDR/Flk-1
CAS Number
[2428381-49-9]
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
